Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe page now lacks the Melanoma label and related-topic links, indicating a pruning of topic signals and external resource references within the study details.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page, signaling a small metadata/format update.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedMelanoma is added as a topic, and MedlinePlus Genetics is listed as a related resource. The page revision was updated from v3.6.3 to v3.6.4.SummaryDifference0.2%

- Check45 days agoChange DetectedThe related topics section was trimmed by removing Melanoma and MedlinePlus Genetics entries. This reduces the external resources shown alongside the study details.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the page. This update does not alter the study content or functionality.SummaryDifference0.1%

- Check60 days agoChange DetectedMelanoma as a topic and related topics (MedlinePlus Genetics) were added. The page revision updates the version from v3.6.0 to v3.6.2.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.